4.4 Review

Chicago Classification update (version 4.0): Technical review on diagnostic criteria for achalasia

Journal

NEUROGASTROENTEROLOGY AND MOTILITY
Volume 33, Issue 7, Pages -

Publisher

WILEY
DOI: 10.1111/nmo.14182

Keywords

Chicago Classification; dysphagia; high-resolution manometry; hypercontractile esophagus; jackhammer esophagus; non-cardiac chest pain

Funding

  1. NIDDK NIH HHS [K23 DK125266] Funding Source: Medline

Ask authors/readers for more resources

The latest update in the diagnostic criteria for achalasia by Chicago Classification version 4.0 introduced subtypes and definitive/inconclusive diagnostic statements. In cases of inconclusive diagnosis, further testing such as functional lumen imaging probe (FLIP) is recommended for clarification.
The recommended diagnostic criteria for achalasia have been recently updated by Chicago Classification version 4.0 (CCv4.0), the widely accepted classification scheme for esophageal motility disorders using metrics from high-resolution manometry (HRM). CCv4.0 continued upon prior versions by subtyping achalasia into type I, type II, and type III on HRM. The achalasia subgroup of the CCv4.0 Working Group developed both conclusive and inconclusive statements for the HRM diagnoses of achalasia subtypes. Conclusive achalasia on HRM is defined as an abnormal median integrated relaxation pressure (IRP) in the primary position of wet swallows along with 100% failed peristalsis, with type I achalasia having 100% failed peristalsis without panesophageal pressurization (PEP), type II achalasia with PEP in at least 20% of swallows, and type III achalasia having at least 20% of swallows premature with no appreciable peristalsis. An inconclusive HRM diagnosis of achalasia can arise when there is an integrated relaxation pressure (IRP) that is borderline or at the upper limit of normal in at least one position, there is an abnormal IRP in both positions but evidence of peristalsis with PEP or premature swallows, or there is peristalsis in the secondary position after apparent achalasia in the primary position. In patients with dysphagia and an inconclusive HRM diagnosis of achalasia, supportive testing beyond HRM such as a timed barium esophagram (TBE) for functional lumen imaging probe (FLIP) is recommended. The review recommends a diagnostic algorithm for achalasia, discusses therapeutic options for the disease, and outlines future needs on this topic.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Allergy

Montelukast in hospitalized patients diagnosed with COVID-19

Ahsan R. Khan, Christian Misdary, Nikhil Yegya-Raman, Sinae Kim, Navaneeth Narayanan, Sheraz Siddiqui, Padmini Salgame, Jared Radbel, Frank De Groote, Carl Michel, Janice Mehnert, Caleb Hernandez, Thomas Braciale, Jyoti Malhotra, Michael A. Gentile, Salma K. Jabbour

Summary: A retrospective analysis showed that COVID-19 patients treated with montelukast had fewer events of clinical deterioration, suggesting potential clinical activity. Further prospective studies are needed to validate these findings and explore the efficacy of montelukast in treating COVID-19.

JOURNAL OF ASTHMA (2022)

Article Gastroenterology & Hepatology

Upper Esophageal Sphincter Compression Device as an Adjunct to Proton Pump Inhibition for Laryngopharyngeal Reflux

Rena Yadlapati, John E. Pandolfino, Madeline Greytak, Jonathon Cahoon, Mary Clarke, Matthew Clary, Daniel Fink, Paul Menard-Katcher, Andrew M. Vahabzadeh-Hagh, Philip Weissbrod, Samir Gupta, Alexander Kaizer, Sachin Wani

Summary: The study found that the external upper esophageal sphincter compression device as an adjunct to proton pump inhibitor therapy in patients with laryngopharyngeal reflux has potential efficacy in significantly improving symptoms.

DIGESTIVE DISEASES AND SCIENCES (2022)

Article Gastroenterology & Hepatology

Validation of secondary peristalsis classification using FLIP panometry in 741 subjects undergoing manometry

Dustin A. Carlson, Alexandra J. Baumann, Jacqueline E. Prescott, Erica N. Donnan, Rena Yadlapati, Abraham Khan, C. Prakash Gyawali, Wenjun Kou, Peter J. Kahrilas, John E. Pandolfino

Summary: This study systematically evaluated a classification scheme of secondary peristalsis using FLIP panometry by comparing it with primary peristalsis on HRM. The results showed that different contractile response patterns can reflect various pathophysiological states of esophageal peristalsis. The findings suggest that FLIP panometry can facilitate the evaluation of esophageal motility.

NEUROGASTROENTEROLOGY AND MOTILITY (2022)

Article Gastroenterology & Hepatology

Optimal Wireless Reflux Monitoring Metrics to Predict Discontinuation of Proton Pump Inhibitor Therapy

Rena Yadlapati, C. Prakash Gyawali, Melina Masihi, Dustin A. Carlson, Peter J. Kahrilas, Billy Darren Nix, Anand Jain, Joseph R. Triggs, Michael F. Vaezi, Leila Kia, Alexander Kaizer, John E. Pandolfino

Summary: This clinical trial found that a total acid exposure time (AET) of 4.0% is a high-performing prognostic marker for discontinuing PPI therapy. 96 hours of monitoring performed better than 48 hours in predicting the ability to discontinue PPI. These findings have implications for the diagnostic approaches for patients with GERD symptoms who are unresponsive to PPI therapy.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Editorial Material Gastroenterology & Hepatology

Editorial: wireless pH-monitoring - is it time to put away the pH-impredance catheters: Authors' response

Rena Yadlapati, Andrew J. Gawron, John E. Pandolfino

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Gastroenterology & Hepatology

Diagnostic thresholds and optimal collection protocol of salivary pepsin for gastroesophageal reflux disease

Steven D. Ma, Vandan G. Patel, Madeline Greytak, Joshua E. Rubin, Alexander M. Kaizer, Rena H. Yadlapati

Summary: This study assessed the diagnostic performance of salivary pepsin thresholds for GERD and determined the optimal collection protocol of saliva. The results showed that a single fasting AM salivary pepsin concentration can accurately diagnose GERD.

DISEASES OF THE ESOPHAGUS (2023)

Letter Gastroenterology & Hepatology

Chagas' disease achalasia may represent a sub-group of type 2 achalasia without focal elevated pressures

Eric E. E. Low, Rena Yadlapati

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Inter- and intra-rater agreement of interpretation of functional lumen imaging probe in healthy subjects

Rena Yadlapati, C. Prakash Gyawali, Dustin A. A. Carlson, John E. E. Pandolfino, Ronnie Fass, Abraham Khan, Haiying Lin, Joel E. E. Richter, Marcelo F. Vela, Michael F. Vaezi, John O. O. Clarke

Summary: This study assessed the reliability of FLIP measurements and found that normative FLIP parameters can be extracted from FLIP videos using both real-time and post hoc analyses. There is high consistency between novice and experienced users.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Editorial Material Gastroenterology & Hepatology

Modern Day Approach to Extraesophageal Reflux: Clearing the Murky Lens

Rena Yadlapati, Walter W. Chan

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Identifying spastic variant of type II achalasia after treatment with high-resolution manometry and FLIP Panometry

Edoardo Vespa, Domenico A. Farina, Peter J. Kahrilas, Wenjun Kou, Eric E. Low, Rena Yadlapati, John E. Pandolfino, Dustin A. Carlson

Summary: This study found that patients with high PEP values on high-resolution manometry, high FLIP 60 mL pressures, and a spastic-reactive contractile response pattern on FLIP before treatment were more likely to experience post-treatment spasm. Evaluating these features may guide personalized patient management.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Diagnostic methods to measure spastic segment and guide tailored myotomy length in type 3 achalasia

Eric E. E. Low, Aws Hasan, Syed Abbas Fehmi, Michael A. A. Chang, Wilson Kwong, Mary L. L. Krinsky, Gobind Anand, Madeline Greytak, Alexander Kaizer, Rena Yadlapati

Summary: This study aimed to assess the agreement between different detection methods for the length of spastic segments in patients with type 3 achalasia. The results showed a good agreement between the lengths obtained from high-resolution manometry (HRM) and barium esophagram (BE), while there was a negative correlation and poor agreement when compared to endoscopic ultrasound (EUS). This suggests that HRM is more commonly used and the role of EUS in determining tailored myotomy length for type 3 achalasia is uncertain.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Medicine, Research & Experimental

A Linked Electronic Medical Record-Claims Analysis of the Clinical and Economic Outcomes of Patients Coded for Erosive Esophagitis in the United States

Rena Yadlapati, Katherine Cappell, Robert Sedgley, Corey Pelletier, Rinu Jacob, Machaon Bonafede, Shailja C. Shah

Summary: Erosive esophagitis (EE) is a severe form of gastroesophageal reflux disease commonly treated with proton pump inhibitors (PPIs). This retrospective cohort study in the USA found that patients with EE commonly switch between different PPIs, and higher PPI use is associated with increased healthcare costs.

ADVANCES IN THERAPY (2023)

Review Gastroenterology & Hepatology

Quality of Life and Laryngopharyngeal Reflux

Kelli Liu, Amanda Krause, Rena Yadlapati

Summary: Laryngopharyngeal reflux (LPR) is a syndrome characterized by the reflux of gastric contents into the pharynx or larynx, causing symptoms such as cough, throat clearing, sore throat, globus, and dysphonia. Unlike gastroesophageal reflux disease (GERD), LPR is not well-studied, and there is no gold standard for diagnosis. Further research is needed to explore the relationship between symptom burden, acid reflux, and quality of life, anxiety, and depression in LPR patients and guide treatment strategies.

DIGESTIVE DISEASES AND SCIENCES (2023)

Letter Gastroenterology & Hepatology

Tailored myotomy for the treatment of type 3 achalasia: Is there a role for the functional lumen imaging probe?

Eric E. Low, Syed A. Fehmi, Rena Yadlapati

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Economics

Healthcare costs among patients with newly diagnosed helicobacter pylori infection in the United States: a linked claims-EHR study

Shailja Shah, Katherine Cappell, Robert Sedgley, Corey Pelletier, Rinu Jacob, Machaon Bonafede, Rena Yadlapati

Summary: This study aimed to characterize the cost drivers of patients with Helicobacter pylori (HP) and estimate the cost savings associated with successful eradication compared to failed eradication. The results showed that the healthcare costs of HP patients are influenced by comorbidities and there are significant cost savings for patients with successful HP eradication in specific HP-related conditions.

JOURNAL OF MEDICAL ECONOMICS (2023)

No Data Available